|
0
|
|
Losartan and prednisolone for post-COVID syndrome and cardiac inflammation: a randomized, double-blind, placebo-controlled trial.
(nature.com)
|
Puntmann VO
…
Berry C
Nature Communications
2026-07-30
|
#clinical trial
#cardiology
#post-covid
#inflammation
#immunomodulation
|
|
0
|
|
Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.
(linkinghub.elsevier.com)
|
Mora P
…
Rosenstock J
The Lancet
2026-07-30
|
#diabetes
#clinical trial
#pharmacology
#therapeutics
|
|
0
|
|
Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial.
(nature.com)
|
Armstrong SB
…
Davis AK
Communications Medicine
2026-07-30
|
#psychedelics
#ptsd
#clinical trial
#psychotherapy
#treatment-resistant
|
|
0
|
|
Phase 2b Trial of a Na(V)1.8 Inhibitor for Acute Pain.
(nejm.org)
|
Singla N
…
Loflin M
New England Journal of Medicine
2026-07-30
|
#clinical trial
#analgesia
#pain
#postoperative
#sodium-channels
|
|
0
|
|
Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.
(linkinghub.elsevier.com)
|
Mora P
…
Rosenstock J
The Lancet
2026-07-30
|
#diabetes
#clinical trial
#pharmacology
#therapeutics
|